How will consumer expectations drive precision medicine forward?
May 9th, 2017 1:00PM EST
In January 2015, President Obama announced the Precision Medicine Initiative; a bold new research effort to revolutionize how we improve health and treat disease in the United States. Its goal is to bring precision medicine, an approach to disease management that considers individual variability in genes, environment, and lifestyle, into the field of cancer and then ultimately into all areas of health and health care; thus moving away from the “one size fits all” approach for treatments.
Advances in Precision Medicine have already led to powerful new discoveries and new treatments that are tailored to an individual’s specific genetic makeup or genetic profile. This is one step in transforming the way we can treat disease.
As consumers show more and more interest in their individual genetic information, the pressure for healthcare delivery organizations to personalize diagnosis and treatment plans will intensify. Those who are slow to adopt will likely lose customers in this new era of data driven healthcare.
In this session, we will explore:
The market and technology trends that are accelerating the healthcare sector’s adoption of Precision Medicine
The practice areas that are getting the most traction with early adopters that offer the greatest promise
The opportunities for the health IT industry to bring innovative solutions that address current technology challenges
The expectations we should have on providers, payers, pharma, policy and patients to accelerate precision medicine
Dell EMC Healthcare brings innovation to help you advance healthcare within the digital era. Becoming a digital healthcare organization means transforming operating models, people, and process as well as IT. We uniquely power this digital transformation by delivering best-in-class technology for applications, data, infrastructure and security – from the edge to the core to the cloud.
Chief Information Officer
Translational Genomics Research Institute (TGen)
Mr. James Lowey is the Chief Information Officer at the Translational Genomics Research Institute (TGen). Mr. Lowey Provides the strategic vision and leadership for all aspects related to Information Technology at TGen. This includes working closely with Scientific and Administrative leadership to ensure the right technology is in place at the right time. Some of this technology includes the TGen HPC environment, a dedicated scientific resource including a three thousand-plus core cluster supercomputer, various SMP and GPU based computational resources and more than three Petabytes of storage. Mr. Lowey is also responsible for the security and availability of networks, servers and cloud-based services for a variety of scientific and administrative applications as well as data repositories and transfer mechanisms for both TGen and its collaborators.
Healthcare Strategist, Healthcare & Life Sciences
Jennifer is a healthcare strategist within Dell EMC’s Healthcare & Life Sciences division. She is responsible for providing strategic insight to help Dell EMC advance its support of healthcare organizations, medical professionals and patients through information-enabled healthcare. She has spent more than 20 years helping advance the healthcare industry with new opportunities and emerging technology. She works closely with healthcare customers and practitioners to bring them the right mix of technology innovation and solutions that will help them navigate through the ever-changing and increasingly complex world of healthcare.
Marketing Director for Health and Life Sciences
Bryce Olson is Intel's Marketing Director for Health and Life Sciences. One of the areas he focuses on is bringing technology and science together in the exciting area of genomics and personalized medicine with a powerful message on how this saves lives. Genomic sequencing and precision medicine gave him a life he didn’t think he’d get to live. Bryce is inspired by connecting the advances in life sciences into clinical settings and helping patients understand these new opportunities. He also started FACTS (Fighting Advanced Cancer Through Songs), a new movement that uses the power of music to build awareness for a new way to fight cancer and bring molecular testing and precision medicine to as many advanced cancer patients as possible.